GlassScriptPhysician profile
Boris Kapelnik
NPI 1013963057
$5,920.79
in general payments reported to CMS, 2019-2025
21 companies · $1,494 in 2025
The $1,494 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $809 · 2020: $460 · 2021: $735 · 2022: $563 · 2023: $801 · 2024: $1,059 · 2025: $1,494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,354.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $902.16 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Alcon Vision LLC | $630.34 | 2023-2025 | Simbrinza, Precision7 |
| Johnson & Johnson Vision Care, INC. | $578.25 | 2021-2025 | Acuvue |
| Novartis Pharmaceuticals Corporation | $529.31 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $457.62 | 2021-2025 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $427.96 | 2019-2021 | |
| Eyevance Pharmaceuticals LLC | $364.38 | 2020-2023 | Tobradex St |
| Tarsus Pharmaceuticals, INC. | $337.86 | 2024-2025 | Xdemvy |
| Shire North American Group INC | $285.34 | 2019 | |
| Aerie Pharmaceuticals, INC. | $259.55 | 2019-2021 | |
| Allergan, INC. | $248.13 | 2019-2021 | |
| Biotissue Holdings INC. | $219.07 | 2023-2024 | |
| Harrow Eye, LLC | $193.26 | 2024-2025 | Vevye |
| Oyster Point Pharma, INC. | $192.11 | 2022-2025 | Tyrvaya, Ryzumvi |
| Dompe US, INC. | $82.33 | 2024-2025 | Oxervate |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $73.48 | 2022-2023 | Tearcare System |
| Thea Pharma INC. | $55.63 | 2024 | Iyuzeh |
| Visioneering Technologies, INC. | $30.69 | 2021-2023 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Abbvie INC. | $16.68 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Kapelnik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.